On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – PetMedix
On Sep 8, 2021 PetMedix closed a Series B round and raised £27,000,000 from Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, Parkwalk Advisors, Tencent, featuring […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Series D – INBRACE
On Sep 8, 2021 INBRACE closed a Series D round and raised $102,000,000 from BlackRock, Endeavour Vision, Farallon Capital Management, Marshall Wace, MVM Life Science […]
Series A – A-Alpha Bio
On Sep 8, 2021 A-Alpha Bio closed a Series A round and raised $20,000,000 from Lux Capital, Madrona Venture Group, Perceptive Advisors, featuring lead investors […]
Post-IPO Equity – Biostage
On Sep 8, 2021 Biostage closed a Post-IPO Equity round and raised $2,600,000 from investors, featuring lead investors . About the company: Biostage is located […]
Funding Round – Altoida, Inc.
On Sep 8, 2021 Altoida, Inc. closed a Funding Round round and raised $498,335 from Alzheimer’s Drug Discovery Foundation, featuring lead investors Alzheimer’s Drug Discovery […]
Ciitizen acquired by Invitae
Sep 7, 2021 Invitae has entered into an agreement to acquire Ciitizen in a $325,000,000 deal. Invitae based at San Francisco, California, United States. ” […]
Cornerstone of Recovery acquired by Bradford Health Services
Sep 7, 2021 Bradford Health Services has entered into an agreement to acquire Cornerstone of Recovery . Bradford Health Services based at Warrior, Alabama, United […]
Vector Laboratories acquired by Thompson Street Capital Partners
Sep 7, 2021 Thompson Street Capital Partners has entered into an agreement to acquire Vector Laboratories . Thompson Street Capital Partners based at St Louis, […]
